Guruprasad Aithal
Guruprasad Aithal
NIHR Nottingham Biomedical Research Centre at the Nottingham University Hospitals NHS Trust and the
Verified email at nottingham.ac.uk
Title
Cited by
Cited by
Year
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
GP Aithal, CP Day, PJL Kesteven, AK Daly
The Lancet 353 (9154), 717-719, 1999
15981999
Lanreotide in metastatic enteropancreatic neuroendocrine tumors
ME Caplin, M Pavel, JB Ćwikła, AT Phan, M Raderer, E Sedláčková, ...
New England Journal of Medicine 371 (3), 224-233, 2014
14162014
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ...
The Lancet 387 (10019), 679-690, 2016
11082016
HLA-B* 5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
AK Daly, PT Donaldson, P Bhatnagar, Y Shen, I Pe'er, A Floratos, MJ Daly, ...
Nature genetics 41 (7), 816-819, 2009
10072009
Case definition and phenotype standardization in drug‐induced liver injury
GP Aithal, PB Watkins, RJ Andrade, D Larrey, M Molokhia, H Takikawa, ...
Clinical Pharmacology & Therapeutics 89 (6), 806-815, 2011
8132011
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
IN Guha, J Parkes, P Roderick, D Chattopadhyay, R Cross, S Harris, ...
Hepatology 47 (2), 455-460, 2008
7672008
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
SA Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, Romero ...
Gastroenterology 150 (5), 1147-1159, 2016
7612016
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
GP Aithal, JA Thomas, PV Kaye, A Lawson, SD Ryder, I Spendlove, ...
Gastroenterology 135 (4), 1176-1184, 2008
7042008
Guidelines on the management of ascites in cirrhosis
KP Moore, GP Aithal
Gut 55 (suppl 6), vi1-vi12, 2006
6022006
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
YL Liu, HL Reeves, AD Burt, D Tiniakos, S McPherson, JBS Leathart, ...
Nature communications 5 (1), 1-6, 2014
4772014
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
SL Friedman, V Ratziu, SA Harrison, MF Abdelmalek, GP Aithal, ...
Hepatology 67 (5), 1754-1767, 2018
4482018
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles
MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ...
Gastroenterology 141 (1), 338-347, 2011
4042011
Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management
V Ramappa, GP Aithal
Journal of clinical and experimental hepatology 3 (1), 37-49, 2013
3572013
Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes
AK Daly, GP Aithal, JBS Leathart, RA Swainsbury, TS Dang, CP Day
Gastroenterology 132 (1), 272-281, 2007
3332007
Drug-induced liver injury: recent advances in diagnosis and risk assessment
GA Kullak-Ublick, RJ Andrade, M Merz, P End, A Benesic, AL Gerbes, ...
Gut 66 (6), 1154-1164, 2017
3142017
Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical …
JM Dumonceau, M Polkowski, A Larghi, P Vilmann, M Giovannini, ...
Endoscopy 43 (10), 897, 2011
3122011
Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001
J West, H Wood, RFA Logan, M Quinn, GP Aithal
British journal of cancer 94 (11), 1751-1758, 2006
2552006
The natural history of histologically proved drug induced liver disease
PG Aithal, CP Day
Gut 44 (5), 731-735, 1999
2321999
Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity
GP Aithal, L Ramsay, AK Daly, N Sonchit, JBS Leathart, G Alexander, ...
Hepatology 39 (5), 1430-1440, 2004
2312004
EASL clinical practice guidelines: drug-induced liver injury
RJ Andrade, GP Aithal, ES Björnsson, N Kaplowitz, GA Kullak-Ublick, ...
Journal of hepatology 70 (6), 1222-1261, 2019
2102019
The system can't perform the operation now. Try again later.
Articles 1–20